SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-06-015863
Filing Date
2006-03-10
Accepted
2006-03-10 17:16:32
Documents
4
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-2364_210ka.htm 10-K/A 185738
2 302 CERTIFICATION a06-2364_2ex31d3.htm EX-31.3 10660
3 302 CERTIFICATION a06-2364_2ex31d4.htm EX-31.4 12327
4 906 CERTIFICATION a06-2364_2ex32d2.htm EX-32.2 6838
  Complete submission text file 0001104659-06-015863.txt   217002
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19700 | Film No.: 06680194
SIC: 2834 Pharmaceutical Preparations